Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06790160 · ClinicalTrials.gov registry record

Study of Patients Being Treated With Anti-obesity Medication

A clinical trial of Obesity and Overweight, sponsored by Texas Tech University.

Recruiting
Registry status
100
Enrollment target
1
Study location

NCT06790160 is a study of Obesity and Overweight that is actively recruiting participants, run by Texas Tech University. The registered enrollment target is 100 participants, below the 462-participant average among 27 other Obesity and Overweight trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06790160, a study of Obesity and Overweight, is actively recruiting participants, sponsored by Texas Tech University.

RECRUITING
Registry status
100 participants
Enrollment target
1
Study location

Study Summary

The goal of this observational study is to learn about the real-world effects of selected obesity medications in adults undergoing medical weight management. The main outcomes of interest are changes in body composition, routine clinical markers, muscular performance, and nutritional intake over the course of treatment. Additionally, the influence of lifestyle factors on changes in these outcome variables will be examined. Participants beginning treatment with selected obesity medications will undergo periodic body composition and muscular performance testing, as well as complete online surveys about their nutritional intake and physical activity and exercise participation. Additionally, routinely collected clinical information will be evaluated.

Conditions Studied

Study Locations (1)

Texas

  • Texas Tech University - Lubbock

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2025-01-31
Est. Completion 2027-02

Sponsor

Texas Tech University

69 total trials

What the Registry Record Tells You About NCT06790160

The ClinicalTrials.gov registry entry for NCT06790160 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 462-participant average among 27 other Obesity and Overweight trials with a reported enrollment target (78% lower). The listed sponsor is Texas Tech University, which has 69 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Obesity and Overweight appearing as the primary indexed condition, and to 0 interventions.

NCT06790160 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT06790160 about?

NCT06790160 is a clinical study titled "Study of Patients Being Treated With Anti-obesity Medication". The goal of this observational study is to learn about the real-world effects of selected obesity medications in adults undergoing medical weight management. The main outcomes of interest are changes in body composition, routine clinical markers, muscular performance, and nutritional intake over the...

What is the current status of trial NCT06790160?

This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2025-01-31. Estimated completion is 2027-02.

What conditions does trial NCT06790160 study?

This clinical trial studies the following conditions: Obesity and Overweight.

Who is sponsoring clinical trial NCT06790160?

This trial is sponsored by Texas Tech University, which has 69 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06790160 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity and Overweight

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.